PK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET
暂无分享,去创建一个
William E. Klunk | Chester A. Mathis | Ronald L. Hamilton | Clayton A. Wiley | Brian J. Lopresti | W. Klunk | C. Mathis | B. Lopresti | C. Wiley | U. Apte | S. Venneti | R. Hamilton | Guoji Wang | Sriram Venneti | Guoji Wang | Udayan M. Apte
[1] Paul Cumming,et al. Up‐regulation of PK11195 binding in areas of axonal degeneration coincides with early microglial activation in mouse brain , 2006, The European journal of neuroscience.
[2] J. Julien,et al. Bone Marrow-Derived Microglia Play a Critical Role in Restricting Senile Plaque Formation in Alzheimer's Disease , 2006, Neuron.
[3] S. DeKosky,et al. Binding of the Positron Emission Tomography Tracer Pittsburgh Compound-B Reflects the Amount of Amyloid-β in Alzheimer's Disease Brain But Not in Transgenic Mouse Brain , 2005, The Journal of Neuroscience.
[4] F. LaFerla,et al. Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.
[5] D. Wilcock,et al. Dynamic Complexity of the Microglial Activation Response in Transgenic Models of Amyloid Deposition: Implications for Alzheimer Therapeutics , 2005, Journal of neuropathology and experimental neurology.
[6] S. Karlsson,et al. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to β-amyloid deposition in APP/PS1 double transgenic Alzheimer mice , 2005, Neurobiology of Disease.
[7] E. Masliah,et al. Aβ vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease , 2005, Neurology.
[8] M. Graeber,et al. A Free Community Approach to Classifying Disease , 2004, PLoS medicine.
[9] D. Wilcock,et al. Passive Amyloid Immunotherapy Clears Amyloid and Transiently Activates Microglia in a Transgenic Mouse Model of Amyloid Deposition , 2004, The Journal of Neuroscience.
[10] T. Guilarte,et al. Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization. , 2004, Brain : a journal of neurology.
[11] S. Wisniewski,et al. PET imaging of brain macrophages using the peripheral benzodiazepine receptor in a macaque model of neuroAIDS. , 2004, The Journal of clinical investigation.
[12] I. Ferrer,et al. Neuropathology and Pathogenesis of Encephalitis following Amyloid β Immunization in Alzheimer's Disease , 2004, Brain pathology.
[13] K. Davis,et al. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. , 2003, JAMA.
[14] C. Holmes,et al. Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report , 2003, Nature Medicine.
[15] D. Schenk,et al. The role of microglia in Alzheimer’s disease: friend or foe? , 2002, Neurobiology of Aging.
[16] A. Hofman,et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. , 2001, The New England journal of medicine.
[17] V. Nguyen,et al. Immunological aspects of microglia: relevance to Alzheimer's disease , 2001, Neurochemistry International.
[18] Roger N Gunn,et al. In-vivo measurement of activated microglia in dementia , 2001, The Lancet.
[19] G. Landreth,et al. Microglial interaction with β‐amyloid: Implications for the pathogenesis of Alzheimer's disease , 2001 .
[20] G. Landreth,et al. Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease. , 2001, Microscopy research and technique.
[21] R B Banati,et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.
[22] R. Motter,et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease , 2000, Nature Medicine.
[23] T. Guilarte,et al. Cellular and Subcellular Localization of Peripheral Benzodiazepine Receptors After Trimethyltin Neurotoxicity , 2000, Journal of neurochemistry.
[24] R. Dempsey,et al. Traumatic Brain Injury Leads to Increased Expression of Peripheral-Type Benzodiazepine Receptors, Neuronal Death, and Activation of Astrocytes and Microglia in Rat Thalamus , 2000, Experimental Neurology.
[25] M. Mattson,et al. Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. , 1999, Science.
[26] R. Motter,et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.
[27] D. Dickson. Microglia in Alzheimer's disease and transgenic models. How close the fit? , 1999, The American journal of pathology.
[28] B. Sommer,et al. Association of microglia with amyloid plaques in brains of APP23 transgenic mice. , 1999, The American journal of pathology.
[29] F. Rossi,et al. beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease. , 1999, The Journal of biological chemistry.
[30] G. Baltuch,et al. Microglia as mediators of inflammatory and degenerative diseases. , 1999, Annual review of neuroscience.
[31] Alan C. Evans,et al. PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis , 1997, Journal of neuroscience research.
[32] D. Borchelt,et al. Accelerated Amyloid Deposition in the Brains of Transgenic Mice Coexpressing Mutant Presenilin 1 and Amyloid Precursor Proteins , 1997, Neuron.
[33] Joseph S. Beckman,et al. Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease , 1997, The Journal of Neuroscience.
[34] W F Stewart,et al. Risk of Alzheimer's disease and duration of NSAID use , 1997, Neurology.
[35] R B Banati,et al. PK (‘peripheral benzodiazepine’) – binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK 11195 binding to activated microglia , 1997, Journal of neurocytology.
[36] N L Foster,et al. PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[37] D. Schober,et al. Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[38] Richard S. J. Frackowiak,et al. Macrophage and Astrocyte Populations in Relation to [3H]PK 11195 Binding in Rat Cerebral Cortex following a Local Ischaemic Lesion , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[39] P. Mcgeer,et al. Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.
[40] A. Lbert,et al. Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease , 2022 .